Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1993 | 06-1993 | 03-1993 | 12-1992 | 09-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,148 | 1,459 | 3,754 | 4,073 | 4,757 |
| Marketable Securities | 1,946 | 1,946 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 3 | 7 |
| Other current assets | 61 | 53 | 53 | 25 | 58 |
| TOTAL | $3,155 | $3,458 | $3,807 | $4,100 | $4,823 |
| Non-Current Assets | |||||
| PPE Net | 74 | 70 | 57 | 41 | N/A |
| Other Non-Current Assets | 6 | 6 | 4 | 4 | 5 |
| TOTAL | $80 | $77 | $61 | $45 | $5 |
| Total Assets | $3,216 | $3,519 | $3,862 | $4,136 | $4,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48 | 33 | 33 | 60 | 154 |
| TOTAL | $48 | $33 | $33 | $60 | $154 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 67 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $67 |
| Total Liabilities | $48 | $33 | $33 | $60 | $221 |
| Shareholders' Equity | |||||
| Common Shares | 5,525 | 5,525 | 5,525 | 5,525 | 5,525 |
| Retained earnings | -2,518 | -2,199 | -1,858 | -1,610 | -990 |
| Other shareholders' equity | 67 | 67 | 67 | 67 | 0 |
| TOTAL | $3,168 | $3,487 | $3,828 | $4,076 | $4,628 |
| Total Liabilities And Equity | $3,216 | $3,519 | $3,862 | $4,136 | $4,850 |